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Abstract
The nucleotide adenosine-59-monophosphate (AMP) can be released by various cell types and has been shown to elicit
different cellular responses. In the extracellular space AMP is dephosphorylated to the nucleoside adenosine which can then
bind to adenosine receptors. However, it has been shown that AMP can also activate A1 and A2a receptors directly. Here we
show that AMP is a potent modulator of mouse and human dendritic cell (DC) function. AMP increased intracellular Ca
2+
concentration in a time and dose dependent manner. Furthermore, AMP stimulated actin-polymerization in human DCs and
induced migration of immature human and bone marrow derived mouse DCs, both via direct activation of A1 receptors.
AMP strongly inhibited secretion of TNF-a and IL-12p70, while it enhanced production of IL-10 both via activation of A2a
receptors. Consequently, DCs matured in the presence of AMP and co-cultivated with naive CD4
+CD45RA
+ T cells inhibited
IFN-c production whereas secretion of IL-5 and IL-13 was up-regulated. An enhancement of Th2-driven immune response
could also be observed when OVA-pulsed murine DCs were pretreated with AMP prior to co-culture with OVA-transgenic
naı ¨ve OTII T cells. An effect due to the enzymatic degradation of AMP to adenosine could be ruled out, as AMP still elicited
migration and changes in cytokine secretion in bone-marrow derived DCs generated from CD73-deficient animals and in
human DCs pretreated with the ecto-nucleotidase inhibitor 59-(alpha,beta-methylene) diphosphate (APCP). Finally, the
influence of contaminating adenosine could be excluded, as AMP admixed with adenosine desaminase (ADA) was still able
to influence DC function. In summary our data show that AMP when present during maturation is a potent regulator of
dendritic cell function and point out the role for AMP in the pathogenesis of inflammatory disorders.
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Introduction
Different cell types such as activated platelets [1], neutrophils
[2], and eosinophils [3] have been shown to release adenosine-59-
monophosphate (AMP). Furthermore hydrolysis of ATP or ADP
by ecto-ATPases (CD39) leads to the accumulation of AMP in the
extracellular space, whereas AMP itself can be degraded by ecto-
59-nucleotidase (CD73) to adenosine which is a well characterized
signaling molecule binding to different adenosine receptor
subtypes. The biological effects of AMP include bronchoconstric-
tion [4], stimulation of DNA synthesis, and mitogenesis [5]. In the
past, most of the effects elicited by AMP have been attributed to
the fact that AMP can be degraded rapidly to adenosine.
However, there is good evidence that AMP can also directly bind
to A1 and A2A receptors without being dephosphorylated to
adenosine before [6,7]. In contrast, GPR80 (GPR99) which has
been claimed to be a receptor specific for AMP has turned out to
be a receptor for citric acid cycle intermediates but not for AMP
[8,9].
Dendritic cells (DCs) are antigen presenting cells specialized in
activating naive T cells thereby initiating primary immune
responses [10,11]. DCs originate from hematopoietic stem cells
and migrate into target sites to capture antigens [11]. During
circulation through the body DCs undergo maturation, a process
that entails acquisition of high levels of surface MHC and co-
stimulatory molecules, as well as the production of different
cytokines and chemokines. In secondary lymphoid organs DCs
play a crucial role in the development of Th1/Th2-driven
immune responses through the release of cytokines and chemo-
kines [11]. Additionally, they also produce several pro-inflamma-
tory cytokines including TNF-a, IL-1b, IL-6, and IL-8 profoundly
affecting the outcome of inflammatory reactions [12]. Hence DCs
have been shown to be involved in the pathogenesis of
inflammatory disorders such as bronchial asthma [13,14,15].
DCs express different purinergic receptors including adenosine
receptors. Consequently extracellular nucleotides such as ATP,
ADP, UTP, or UDP have been demonstrated to affect maturation,
PLoS ONE | www.plosone.org 1 May 2012 | Volume 7 | Issue 5 | e37560migration, cytokine secretion, and T-cell priming capacity of DCs
[16,17,18,19,20]. However, little is known about the influence of
AMP on dendritic cell function.
Materials and Methods
Ethics statement
The use of human blood samples was approved by the ethics
committee at the University of Freiburg (Approval ID 03/10).
Written consent was obtained from all participants.
All experiments involving animals were carried out in strict
accordance with the national protection of Animals act. Animal
experiments were approved by the local animal ethics committee
(Regierungspra ¨sidium Freiburg).
Preparation of human dendritic cells
Peripheral mononuclear cells were isolated from heparin-
anticoagulated blood of healthy volunteers using a Ficoll gradient.
After separation, the leukocyte-containing pellet was resuspended
in 2 ml of PBS containing 2 mM EDTA and 0.5% BSA. Cells
were separated with anti-CD14 mAb-coated MicroBeads using
Macs single use separation columns from Miltenyi Biotec (Bergisch
Gladbach, Germany). The CD14
+ cells were cultured for 5 days in
RPMI 1640 medium containing 10% FCS, 1% glutamine, 50 IU/
ml penicillin, 50 mg/ml streptomycin, 1,000 U/ml IL-4, and
10,000 U/ml GM-CSF (Natutec, Frankfurt, Germany) at 37uCi n
a humidified atmosphere with 5% CO2. Maturation of DCs was
induced by 48 h incubation in the presence of 3 mg/ml LPS
(Sigma-Aldrich, Germany).
Intracellular Ca
2+ measurements
Intracellular-free Ca
2+ was measured in fura-2/AM-loaded DCs
using the digital fluorescence microscope unit Attofluor (Zeiss,
Oberkochen, Germany), as previously described [19]. Briefly, DCs
were incubated with 2610
26 M fura-2/AM for 30 min at 37uCi n
aC a
2+- and Mg
2+-free buffer. Cells were then washed twice and
resuspended in the same buffer containing 1.5 mM CaCl2 and
MgCl2. Cells were stimulated with nucleotides and [Ca
2+]i
changes determined with the 340/380 excitation ratio at an
emission wavelength of 505 nm.
Actin polymerization
The content of filamentous actin was analyzed by flow
cytometry with NBD-phallacidin staining [19]. Briefly, aliquots
(50 mL) of DCs suspensions (5610
5 cells/mL) were withdrawn at
the indicated time intervals and fixed in a 7.4% formaldehyde
buffer. After 1 h, cells were mixed with the staining cocktail
containing 7.4% formaldehyde, 0.33610
26 M NBD-phallacidin,
and 1 mg/ml lysophosphatidylcholine. The mean channel num-
ber of the fluorescence intensity of each sample was measured by
flow cytometry (FacsCalibur, BD, Franklin Lakes, USA). The
relative f-actin content in comparison to the medium control was
calculated.
Mice
C57BL/6 mice, OVA-TCR transgenic OT-II mice on a C57/
Bl6 mice background (6–8 week-old) were bred at the animal
facilities at the University Hospital Freiburg. CD73-deficient mice
(CD732/2) on C57BL/6 background were kindly provided by
Linda Thompson and backcrossed with our C57BL/6 strains. All
experiments were performed according to institutional guidelines
of the animal ethics committee from the German government.
Generation of bone marrow-derived DCs (BMDCs)
DCs were prepared as previously described [21,22]. Briefly,
bone marrow cells from wt and CD73-deficient (CD732/2) mice
(both on C57BL/6 background) were grown in RPMI 1640
medium supplemented with gentamycin, 2-mercaptoethanol, 10%
FCS (Biocell Laboratories), and recombinant murine GM-CSF
(200 IU/ml). On days 3, 6, and 8 the medium was changed and
GM-CSF was added. On day 9 cells were pulsed overnight with
100 mg/ml LPS-low OVA (MW 45 kDa/Worthington Biochem-
icals, Lakewood, USA) or vehicle. In some experiments cells were
stimulated with different concentrations of AMP, adenosine, or
adenosine desaminase 30 min prior to overnight pulsing. The next
day supernatants for cytokine analysis were harvested and non-
adherent DCs were collected and washed to remove free OVA.
The purity of bone marrow–derived DCs was greater than 90% as
determined by CD11c staining.
Migration assay
Experiments were performed in triplicate using 24-well
transwell chambers with a pore size of 5 mM (Nunclon,
Langenselbold, Germany) [21,22]. Buffer or different concentra-
tions of AMP were added into the lower compartment wells.
Human or murine cells (10
5 cells/well) were added to the upper
compartment and incubated at 37uC for 90 min in a humidified
atmosphere. Migrated DCs in the lower chamber were stained
with trypan blue and counted in a hematocytometer. Results are
shown as chemotatic index, calculated as the number of cells in the
lower chamber containing the different stimuli divided by the
number of cells in the chamber containing medium alone.
Cytokine measurements
To measure cytokine levels in the supernatants of DCs, human
or murine cells (2610
5/well) were stimulated with the indicated
concentrations of AMP or adenosine (purchased from Sigma,
Deisenhofen, Germany) 1 hour or 30 min prior to overnight
pulsing with LPS (3 mg/ml) or OVA. The next day cell-free
supernatants were harvested and the presence of IL-10, IL-12 and
TNF-a was assessed by ELISA (R&D systems, Minneapolis, USA).
T-cell differentiation assay
Peripheral mononuclear cells were separated from buffy coats
using a Ficoll (GE Healthcare, Uppsala, Sweden) gradient. After
separation, the leukocyte-containing pellet was resuspended in
2 ml of PBS containing 2 mM EDTA and 0.5% BSA. Cells were
separated with CD4
+ T-cell isolation kit (Miltenyi, Bergisch
Gladbach, Germany). CD4
+ T-cells were depleted of CD45RO
+
cells with CD45RO microbeads (Miltenyi, Bergisch Gladbach,
Germany). 5610
5 CD4
+CD45RA
+ cells were co-cultured with
1610
5 DCs for 5 days. After 5 days cells were re-stimulated with
10 ng/mL phorbol myristate acetate (PMA) and 1 mg/mL
ionomycin (Sigma-Aldrich, Taufkirchen, Germany). After addi-
tional 2 days supernatants were collected and levels of IL-5, IL-13,
and IFN-c were analyzed by ELISA (R&D systems, Minneapolis,
USA).
Activation of OVA-specific naive and effector T cells by
mouse DCs
Bone marrow (BM) DCs generated from wt and CD732/2
animals were pulsed with 100 mg/ml OVA or vehicle overnight.
DCs were also treated for 30 min with AMP (AMP-OVA-DCs) or
vehicle (OVA-DCs) before addition of OVA. DCs (1610
4) were
collected, washed and co-cultured for 4 days with naive OVA-
specific CD4+ T cells (1610
5) purified from un-manipulated OTII
AMP and Dendritic Cells
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plates. After 4 days, supernatants were harvested and analyzed for
the presence of IFN-c, IL-5, and IL-13 by ELISA (R&D systems,
USA).
Flow cytometry
Maturation status of DCs was analyzed via flow cytometry.
Cells were stained for the expression of the cell surface markers
CD40, CD80, CD83 and CD86 (antibodies were from Immuno-
tools, Frisoythe, Germany). In all experiments, dead cells were
excluded from analysis using propidium iodide. Analysis was
performed on a FacsCalibur flow cytometer, using Cellquest and
FlowJo software.
Statistical Analysis
If not stated otherwise the statistical significance of differences
between samples was calculated using ANOVA, followed by
Bonferroni comparison test. Differences were considered signifi-
cant if p,0.05.
Results
AMP induces intracellular Ca
2+ transients in immature
dendritic cells
Intracellular Ca
2+ transients are crucial for cellular responses
such as chemotaxis or cytokine secretion. Stimulation of immature
monocyte-derived DCs resulted in a time- and dose- dependent
increase in intracellular Ca
2+ concentration (Fig. 1). Maximal
effect was seen at 10
24 M AMP, while half-maximal effect was
seen at 10
25 M.
AMP stimulates actin polymerization and migration of
immature dendritic cells
Both extracellular nucleotides and adenosine are known
chemotactic stimuli for human immature dendritic cells [17,19].
As polymerization of the intracellular actin network is a
prerequisite for oriented migration, the effect of AMP on this
process was analyzed. Figure 2A shows that AMP caused a rapid
and transient polymerization of the actin network in immature
DCs, with an increase in f-actin content of about 50% within
25 seconds. Maximal and half-maximal effects were seen at an
AMP concentration of 10
25 M and 10
27 M, respectively.
Migration of DCs in response to AMP was analyzed using the
modified transwell system. As shown in Figure 2B AMP dose-
dependently stimulated migration of immature DCs with maximal
Figure 1. AMP triggers intracellular Ca
2+ transients in human immature monocyte-derived dendritic cells. Cells were loaded with the
Ca
2+ indicator fura-2/AM and stimulated with the indicated concentrations of AMP. One representative experiment of at least 5 similar is shown.
doi:10.1371/journal.pone.0037560.g001
Figure 2. AMP stimulates actin polymerization and migration
in immature dendritic cells. Cells were stimulated with the indicated
AMP concentrations. The relative f-actin content after 25 s was analyzed
(A). Data are means 6 SE of 4 independent experiments (n=4). DCs
were exposed to the indicated concentrations of AMP for 90 min at
37uC in a Boyden chamber (B). The chemotactic index was calculated.
Data are means 6 SEM of 4 independent experiments (n=4). * p,0.05
** p,0.01 *** p,0.001.
doi:10.1371/journal.pone.0037560.g002
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26 M and half-maximal response
at 10
25 M. However, AMP had no chemotactic activity on LPS-
matured DCs (data not shown).
AMP regulates cytokine secretion of human dendritic
cells
Both extracellular nucleotides and adenosine have been shown
to be potent modulators of cytokine secretion. Therefore, the effect
of AMP on cytokine release by LPS-matured DCs was analyzed.
Figure 3. AMP regulates cytokine secretion of human mono-
cyte-derived dendritic cells. 0.2610
6 cells were stimulated with the
indicated concentrations of AMP. LPS (3 mg/ml) or vehicle was added
one hour later. Cells were incubated for 24 h and contents of TNF-a (A),
IL-12p70 (B), and IL-10 (C) by unpulsed immature dendritic cells (iDCs)
or LPS-pulsed mature dendritic cells (mDCs) were determined by ELISA.
Data are means 6 SEM of triplicate culture. One representative
experiment of at least 5 similar is shown (n=5). For the average of all
3 experiments see the Supplemental Information (Fig. S1A–C).
doi:10.1371/journal.pone.0037560.g003
Figure 4. AMP influences T-cell priming capacity of human
monocyte-derived dendritic cells. Immature DCs were left untreat-
ed or stimulated with 10
24 M AMP or induced to undergo maturation
with LPS in the absence or the presence of AMP for 24 hours. DCs were
then used to prime purified allogeneic CD4
+CD45RA
+ naive T-
lymphocytes. After 5 days, T cells were restimulated with PMA and
ionomycin, supernatants were taken and analyzed for content of IFN-c
(A), IL-5 (B) and IL-13 (C). Data are means 6 SEM of triplicate culture.
One representative experiment of 3 similar is shown (n=3). For the
average of all 3 experiments see the Supplemental Information (Fig. S2).
AMP and Dendritic Cells
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inflammatory cytokines TNF-a and IL-12p70 in a dose dependent
manner. Maximal and half-maximal inhibition of TNF-a secretion
was seen at an AMP concentration of 10
23 M and 10
25 M
respectively (Fig. 3A, Fig. S1A). Maximal and half-maximal effect
on IL-12p70 release was obtained at 10
24 and 10
26 M (Fig. 3B,
Fig. S1B). AMP also modulated production of the regulatory
cytokine IL-10: AMP dose-dependently increased IL-10 secretion
by LPS-primed DCs. Maximal effect was obtained by 10
23 M
AMP, while half maximal response was seen at 10
25 M (Fig. 3C,
Fig. S1C).
Moreover, AMP at a concentration of 10
24 M alone or in
combination with LPS induced increased cell surface expression of
CD83 and CD86 whereas no significant changes could be
observed in CD40 or CD80 expression (data not shown).
AMP affects T-cell priming of human monocyte-derived
dendritic cells
As IL-12p70 is the most important cytokine involved in the
differentiation of Th1 cells, we analyzed cytokine secretion of T
cells induced by DCs primed with AMP. DCs were stimulated
with 10
24 M AMP in the presence or absence of LPS. After 24 h
they were co-cultured for 5 days with allogeneic CD4
+CD45RA
+
T-cells. Cytokine secretion of T cells was analyzed by ELISA.
As shown in Fig. 4 AMP did not alter IFN-c, IL-5, or IL-13
secretion induced by immature DCs. However, treatment of DCs
with AMP during maturation strongly inhibited IFN-c release by
CD4
+CD45RA
+ T-cells, whereas IL-5 and IL-13 secretion was
increased (Fig. 4, Fig. S2).
AMP-induced responses are partially inhibited by
adenosine receptor antagonists
Direct activation of adenosine receptors by AMP has been
shown previously [6,7]. Therefore, experiments with different
adenosine receptor antagonists were performed. Pretreatment of
DCs with the A1 receptor antagonist DPCPX completely blocked
intracellular Ca
2+ increases and actin polymerization induced by
AMP (Table 1). Chemotaxis was partly inhibited by DPCPX and
to a lesser degree by the A3 receptor antagonist MRS1220.
Modulation of cytokine secretion by AMP was almost completely
abrogated by the A2a antagonist ZM241385.
Adenosine independent effect of AMP on cell function of
bone marrow derived DC from WT and CD732/2
animals and of human DC
AMP can be hydrolyzed rapidly to adenosine by membrane
bound 59-nucleotidase (CD73). Expression of CD73 on immature
and mature human monocyte-derived DCs and on murine bone-
marrow derived dendritic cells (BMDCs) has been reported
previously [23]. To better define the role of CD73 in AMP
induced cell function, we performed experiments with BMDCs
generated from wt and CD732/2 animals.
BMDCs were stimulated with increasing concentrations of
AMP and the chemotactic index was calculated as described above
[21,22]. Interestingly, AMP dose-dependently induced migration
in both wt and CD732/2 immature (PBS-pulsed) DCs but not in
OVA-pulsed DCs (data not shown), suggesting that AMP-induced
migration is independent from the extracellular generation of
adenosine (Figure 5A).
BMDCs derived from wt or CD732/2 mice were also
stimulated with AMP or vehicle 30 min prior to pulsing with
OVA or PBS for 24 h. The next day, levels of IL-12, TNF-a and
IL-10 in supernatants were assessed by ELISA. As expected, AMP
suppressed IL-12 and TNF-a production, while IL-10 production
in OVA-pulsed BMDCs was increased (Figure 5B). Of note, AMP
was still able to modulate IL-10, IL-12 and TNF-a release in
OVA-pulsed CD732/2 BMDCs, supporting our assumption that
AMP can affect DC function at least partially independent of
extracellular adenosine generation.
According to our experiments with human monocyte derived
DCs, we questioned whether AMP can also modulate T cell
priming capacity of BMDCs in vitro. Therefore, BMDCs derived
from wt and CD732/2 animals were stimulated with AMP
(10
24 M) or vehicle 30 min prior to overnight pulsing with OVA
or PBS. Cells were then washed twice and co-cultured with
purified naı ¨ve CD4+ T cells from OTII animals. As shown in
Figure 5C, OTII cells which had been co-cultured with AMP-
treated OVA-pulsed DCs derived from wt or CD732/2 animals
Table 1. Characterization of the involved receptors in immature and LPS-differentiated dendritic cells by using selective
antagonists.
Cell type/variable control AMP AMP+DPCPX AMP+ZM241385 AMP+MRS1220
iDCs
Ca
2+ transients 0.8860.05 1.2260.06# 1.0760.04* 1.2460.03 1.2060.04
actin polymerization 1.0060.00 1.9560.18# 1.3560.10* 1.8960.12 1.9060.12
Chemotaxis 1.0060.00 2.1060.20# 1.3060.15* 2.1560.18 1.7060.12*
mDCs
TNF- a 42006590 10506280# 11806450 39506690* 12006380
IL-12p70 19506450 5906280# 6306250 16506390* 5706190
IL-10 4506125 11806220# 9806180 5806175* 9306190
Cells were pre-incubated for 30 min with the A1 receptor antagonist DPCPX, the A2 receptor antagonist ZM241385, and the A3 antagonist MRS1220 at a concentration
of 10
26 M. Ca
2+ transients were analyzed, and the ratio after stimulation with AMP at a concentration of 10
24 M for 10 s is given. Data are means 6 SE (n=3). Actin
polymerization after stimulation with AMP for 25 s was measured and calculated as the ratio between the medium control and stimulated cells. Data are means 6 SE
(n=3). The chemotactic index after stimulation with AMP at 10
25 M was calculated as the ratio between stimulated cells and cells incubated with medium. Data are
means 6 SE (n=3). TNF-a, IL-12p70, and IL-10 release after costimulation with LPS (3 mg/ml) and 10
24 M AMP was calculated, and cytokine content is given as pg/ml/
0.2610
6 cells. Data are means 6 SEM (n=3).
#p,0.05 compared to control,
*p,0.05 compared to AMP-stimulated cells.
doi:10.1371/journal.pone.0037560.t001
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and lower IFN-c levels compared to vehicle treated DCs.
It has been assumed that commercially available AMP could be
contaminated with adenosine. Thus to exclude any effects induced
by contaminating adenosine in our experiments, AMP and
adenosine were ad-mixed with adenosine desaminase prior to
stimulation of BMDCs from wt or CD732/2 animals [24,25,26].
As shown in Figure 6 (A–B), the administration of 1 IU of
adenosine desaminase (ADA) did not significantly influence AMP-
induced migration of immature DCs and cytokine secretion of
OVA-matured DCs, while it strongly reduced adenosine-induced
effects.
In accordance with our results with murine BMDCs, inhibition
of CD73 by APCP did influence neither AMP-induced Ca
2+
transients, nor actin polymerization, nor migration in human
monocytes-derived DCs (table 2).
Discussion
The nucleotide AMP has been demonstrated to have a variety
of biological effects on different cell types [4]. However, the
influence of AMP on human or murine dendritic cells have not
been investigated yet.
Stimulation of immature dendritic cells resulted in intracellular
Ca
2+ transients, actin polymerization, and oriented migration.
Previous studies were able to demonstrate that AMP can bind
directly to A1 receptors [6,7]. Interestingly, A1 receptor activation
has been linked with intracellular Ca
2+ transients, actin polymer-
ization, and migration in human monocytes-derived DCs [16,17].
Pretreatment with the A1 antagonist DPCPX fully blocked
intracellular Ca
2+ transients and actin polymerization and partly
inhibited migration induced by AMP. Hence the involvement of
A1 receptors in AMP-induced activation of human immature DCs
is likely. Additionally, conversion of AMP to adenosine which can
Figure 5. Effect of AMP on CD73+/+ and CD732/2 BMDCs. A) AMP induced migration of immature BMDC generated from CD73+/+ and
CD732/2 animals. DCs were stimulated with the indicated concentrations of AMP for 90 min. Results are shown as chemotatic index, calculated as
the number of cells in the lower chamber containing the different stimuli divided by the number of cells in the chamber containing medium alone.
One representative data out of 3 experiments is shown. B) CD73+/+ and CD732/2 BMDCs were incubated with AMP (10
24 M) or vehicle overnight.
Supernatants were collected and IL-10, IL-12, TNF-a concentrations were measured in supernatants by ELISA. Data are means 6 SEM of triplicate
culture. One representative out of 3 experiments is shown. C) T-cell priming. OVA-DC generated from CD73+/+ and CD732/2 animals were
stimulated with AMP (10
24 M) or vehicle prior to co-culture with OT-II naive T-cells for 5 days in vitro. Levels of IFN-c, IL-5 and IL-13 were measured in
the supernatants. Data are means 6 SEM, n=3. * p,0.05.
doi:10.1371/journal.pone.0037560.g005
AMP and Dendritic Cells
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with AMP might explain why DPCPX only partly blocked
migration induced by AMP. In accordance, migration of DCs was
also slightly inhibited by the A3 antagonist MRS1220. There is
good evidence that the concentration of extracellular nucleotides
e.g. ATP is elevated under hypoxic conditions or in inflamed tissue
[27,28]. Thus it is likely that the concentration of ATP
degradation products such as AMP is increased as well. Similar
to ATP, AMP might act as a signal molecule leading DCs towards
the site of inflammation [19]. However, during the process of
maturation expression of A1 receptors by DCs is down-regulated
[17] and consequently DCs loose their ability to migrate in
response to AMP which might be a prerequisite for departure on
the way to secondary lymphoid organs.
Cytokines and chemokines secreted by dendritic cells are crucial
for the regulation of immune responses [10]. Here we demonstrate
that AMP suppresses the release of the cytokines IL-12p70 and
TNF-a, whereas it up-regulates IL-10 secretion by maturing
dendritic cells. The effects of AMP on cytokine secretion were fully
blocked by the A2a antagonist ZM241385. We and others could
show previously that LPS-matured DCs expressed only A2a and
not A2b receptors [16,17,29] whereas Pacheco and colleagues
reported also expression of A2b receptors, though surface
expression of A2b receptors on mature DCs was very low in this
study [30]. As similar effects on cytokine secretion have been seen
in LPS-primed DCs following activation of A2a receptors this effect
seems to be mediated by direct binding of AMP to this receptor
subtype.
DCs treated with AMP during maturation switched to a low
TNF-a and IL-12p70/high IL-10 producing phenotype. To
evaluate the functional relevance T cell priming capacity of DCs
stimulated with AMP was analyzed. AMP itself did not change T
cell priming capacity of DCs. However, human DCs matured in
the presence of AMP induced a type 2 immune response with up-
regulation of IL-5/IL-13 production and inhibition of IFN-c
release. In line with these findings the Th2-priming capacity of
OVA-pulsed murine DCs was enhanced when DCs were
pretreated with AMP prior to OVA-pulsing. In summary, our
Figure 6. Contaminating adenosine is not involved in AMP induced cell function. A) Adenosine-independent migration of immature BMDC
generated CD73+/+ and CD732/2 in response to AMP. DCs were stimulated with AMP (10
25 M) or Adenosine (10
26 M) in the absence or present of
ADA (1 IU/ml) for 90 min. Results are shown as chemotatic index, calculated as the number of cells in the lower chamber containing the different
stimuli divided by the number of cells in the chamber containing medium alone. One representative out of 3 experiments is shown (n=3). B) CD73+/
+ and CD732/2 BMDCs were incubated with OVA, adenosine (10
24 M) and AMP in the presence or absence of adenosine deaminase/ADA (1 IU/ml)
overnight. Supernatants were collected and IL-10, IL-12, TNF-a concentrations were measured in supernatants by ELISA. Data are means 6 SEM of
triplicate culture. One representative out of 3 experiments is shown (n=3).
doi:10.1371/journal.pone.0037560.g006
AMP and Dendritic Cells
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similar to previous studies in which ATP or adenosine induced
Th2 immunity [16,20].
A concern when conducting experiments with AMP is the
enzymatic breakdown to adenosine by membrane bound ecto-
nucleotidases (CD73) [31] expressed on both human and murine
DCs [23]. For adenosine has been reported to cause similar effects
in human and mouse DCs [16,17,32,33,34], experiments with
DCs generated from CD732/2 and WT animals were
performed. Strikingly AMP was still able to modulate migration,
cytokine production and T cell priming in DCs derived from
CD732/2 animals. In accordance, pretreatment of human DCs
with the ecto-nucleotidase inhibitor APCP did not abrogate Ca
2+
transients, actin polymerization and migration elicited by AMP. In
conclusion, these data clearly demonstrate that AMP can
modulate DC function independently from extracellular adenosine
generation. A direct adenosine-independent effect of AMP on DC
function could further be supported by our finding that the co-
administration of adenosine desaminase, an enzyme metabolizing
extracellular adenosine, did not influence AMP induced cell
responses, ruling out a potential contamination of AMP with
adenosine.
AMP has been used in bronchoprovocation tests for the
diagnosis and monitoring of asthma causing both an early and a
late phase asthmatic reaction. Interestingly, the AMP broncho-
provocation test has greater disease specificity for bronchial
asthma and reflects the degree of inflammation especially in the
peripheral airways better than other tests [35,36,37,38]. Evidence
on the mechanism of adenosine and AMP-mediated bronchocon-
striction has indicated an extracellular site of action and the
stimulation or potentiation of mast cell mediator release [37].
However, our data show that the pro-inflammatory effects of AMP
could also be due to activation of dendritic cells which are essential
for induction and maintenance of asthmatic airway inflammation
[15]. As mentioned above, levels of nucleotides in the extracellular
space are elevated under inflammatory conditions. Previous
studies were able to demonstrate that nucleotides such as ATP
and adenosine are involved in the pathogenesis of inflammatory
diseases [21,22,28,39,40]. Our findings show that AMP, a
degradation product of ATP, is also able to favor Th2 immune
responses by influencing dendritic cell function. Therefore
nucleotide metabolism in the extracellular space might be a
crucial point in different inflammatory disorders.
In the past it has been assumed that the biological properties of
AMP were exclusively due to extracellular conversion of AMP to
adenosine. However, our data suggest that AMP can elicit effects
similar to adenosine by direct binding to A1 and A2a receptors
without being de-phosphorylated before. Therefore, the biological
effects of AMP are likely to be mediated by both AMP and
adenosine [6,7,41].
In summary we were able to demonstrate that AMP is a potent
regulator of maturing dendritic cells linked to chemotaxis, altered
cytokine secretion, and Th2-polarisation. Therefore AMP, similar
to ATP or adenosine, might act as a signaling molecule favoring
Th2-responses.
Supporting Information
Figure S1 Cytokine production by human monocyte-
derived dendritic cells. 0.2610
6 cells were stimulated with the
indicated concentrations of AMP. LPS (3 mg/ml) or vehicle was
added one hour later. Cells were incubated for 24 h and contents
of TNF-a (A), IL-12p70 (B), and IL-10 (C) by LPS-pulsed mature
dendritic cells (mDCs) were determined by ELISA. The index was
calculated (% of LPS-treated cells). Data are mean +/2 SEM for 5
independent experiments (n=5). * p,0.05 compared to LPS-
treated DCs.
(PDF)
Figure S2 AMP influences T-cell priming capacity of
human monocyte-derived dendritic cells. DCs were
induced to undergo maturation with LPS in the absence or the
presence of AMP for 24 hours. DCs were then used to prime
purified allogeneic CD4
+CD45RA
+ naive T-lymphocytes. After 5
days, T cells were restimulated with PMA and ionomycin,
supernatants were taken and analyzed for content of IFN-c, IL-
5 and IL-13. The index was calculated (% of LPS-treated cells).
Data are mean +/2 SEM for 3 independent experiments (n=3). *
p,0.05 compared to LPS-stimulated DCs.
(PDF)
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